Neil Patrick Harris talks about his family, his career, and his support of God’s Love We Deliver.
2020 Advocate: Angela Doyinsola Aina
The United States has the highest maternal mortality rate in the developed world, and African American women bear the disproportionate share of those deaths. Angela Doyinsola Aina, co-director and research lead for the Black Mamas Matter Alliance, is changing that.
2020 Educator: Liliana Campos
For 22 years, Liliana Campos lived in the shadows with no resources to help her cope with the strain of existing in legal limbo as an undocumented immigrant. Today, Campos helps train immigration attorneys, social workers, and mental health professionals who work with immigrants and refugees.
2020 Game Changer: God’s Love We Deliver
Since 1985, God’s Love We Deliver has provided medically tailored meals and nutritional counseling to people in the New York metropolitan area living with severe and chronic illnesses, such as AIDS, cancer, cardiovascular disease, Alzheimer’s disease, and other conditions.
2020 Trailblazer: Robert Bullard, PhD
Robert Bullard, PhD, has earned the title “father of environmental justice” for his more than 40 years of studying, writing about, and pushing for policy changes to reduce the burden of pollution on poor and minority communities.
2020 Innovator: Gary Slutkin, MD
While politicians argue over whether guns or mental health issues are to blame, Gary Slutkin, MD, has another idea. What if violence is a disease we can prevent?
2020 Lifetime Achievement: Bill and Melinda Gates
Since 1997, the Bill and Melinda Gates Foundation has donated more than $50 billion in grants to improve global health and reduce inequities.
From scorpion to immunotherapy: Team repurposes nature’s toxin for CAR T
City of Hope scientists have developed and tested the first chimeric antigen receptor (CAR) T cell therapy using chlorotoxin (CLTX), a component of scorpion venom, to direct T cells to target brain tumor cells, according to a preclinical study published today in Science Translational Medicine. The institution has also opened the first in-human clinical trial to use the therapy.
Read More
Tiny scorpion-derived proteins deliver arthritis drugs to joints in preclinical study
Millions of Americans live with the pain and physical limitations of arthritis and other inflammatory diseases. Steroids and other drugs can offer relief, but they can also come with a host of serious side effects.
Read More
Newly discovered brain response to obesity drug may inform future treatments
The U.S. Food and Drug Administration-approved drug liraglutide has been shown to help obese patients lose weight by suppressing their appetite. However, where and how the drug acts in the brain was not fully understood, until now. A new preclinical study from the Perelman School of Medicine at the University of Pennsylvania, published in Science Translational Medicine today, shows how liraglutide crosses the brain’s blood barrier to engage with a region of the brainstem known as the nucleus tractus solitarius (NTS), which is responsible for balancing food intake and energy expenditure. Filling this gap meets a need that has become a priority for researchers looking for new treatments to help fight the increasing rates of obesity.
Read More
Health Rss 